Aurisco Pharmaceutical Co.,Ltd. Financials

Market Capitalization CN¥10.57 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	23.63
Forward PE	19.72
Price to Sales TTM	CN¥6.26
Price to Book MRQ	CN¥4.00
Enterprise to Revenue	6.23
Enterprise to EBITDA	17.64

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	26.13%
Operating Margin	35.95%
Return on Assets TTM	7.85%
Return on Equity TTM	17.66%

Income Statement

Revenue TTM	CN¥1,624,471,168
Revenue per Share TTM	CN¥4.07
Quarterly Revenue Growth	16.10%
Gross Profit TTM	CN¥964,356,160
EBITDA	CN¥506,461,234
Net Income to Common TTM	CN¥424,537,696
Diluted EPS TTM	CN¥1.06
Quarterly Earnings Growth YoY	24.60%

Balance Sheet

Total Cash MRQ	CN¥1,040,827,904
Total Cash per Share MRQ	CN¥2.56
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	39.00
Current Ratio MRQ	4.30
Book Value per Share MRQ	CN¥6.26

Cash Flow

Operating Cash Flow TTM	CN¥382,388,160
Levered Free Cash Flow TTM	CN¥-96,457,048

605116 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	406,195,234
Float Shares	88,310,906
Avg 10 Volume	4,166,652
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	80.73%
% Held by Institutions	1.06%

Stock Price Summary

Beta	-0.20
Fifty Two Week Low	CN¥18.70
Fifty Two Week High	CN¥26.33
Fifty Two Week Change	18.00%
Day 50 MA	CN¥22.83
Day 200 MA	CN¥22.27

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.16
Forward Annual Dividend Yield	4.63%
Trailing Annual Dividend Rate	CN¥0.29
Trailing Annual Dividend Yield	1.16%
Payout Ratio	27.36%
Dividend Date
Ex Dividend Date	2025-06-20
Last Split Factor
Last Split Date